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Objectives. This study sought to investigate whether the iden-
tification of hibernating myocardium by low dose dobutamine
stress echocardiography (LDSE) may predict an improvement in
functional capacity after moderate exercise training in patients
with ischemic cardiomyopathy. Another objective was to assess
whether exercise training may affect the outcome.
Background. There is evidence that exercise training improves
left ventricular (LV) function as well as functional capacity in
patients with a previous myocardial infarction and LV dysfunc-
tion. We hypothesized that the magnitude of these improvements
might be related to the extent of hibernating myocardium.
Methods. We studied 71 consecutive patients 56 6 9 years old
(mean 6 SD) with chronic heart failure secondary to ischemic
cardiomyopathy (LV ejection fraction [LVEF] <40%). All patients
were in sinus rhythm and were clinically stable during the
previous 3 months. Patients were randomized into two matched
groups. Group T (n 5 36) underwent exercise training at 60% of
peak oxygen uptake (V˙O2) three times a week for 10 weeks. Group
C (n 5 35) did not exercise. At study entry and end, all patients
underwent an exercise test with gas exchange analysis and LDSE
(5 to 20 mg/kg body weight per min).
Results. At baseline, a positive contractile response (CS1) to
LDSE was observed in 317 of 576 segments in group T and 291 of
560 segments in group C. After 10 weeks, peak V˙O2 and peak work
rate increased only in trained patients (peak V˙O2: from 16.2 6 3 to
20.8 6 4 ml/kg per min; work capacity: from 108 6 20 to 131 6
25 W, p < 0.001 vs. group C for both). The presence of CS1 at
baseline was associated with a sensitivity of 70% and a specificity
of 77% for predicting an increase in the functional capacity after
exercise training. Positive and negative predictive values of LDSE
were 84% and 59%, respectively. Independent predictors of car-
diac events were a pre-to-posttraining difference in LVEF at peak
dobutamine infusion and the presence of a viable response at
baseline (p 5 0.004 and 0.008, respectively). The log-rank test
demonstrated that trained patients had a significantly lower
probability of cardiac events during follow-up than sedentary
control patients (p < 0.001).
Conclusions. The presence of hibernating myocardium as as-
sessed by LDSE predicts the magnitude of improvement in
functional capacity after moderate exercise training in patients
with chronic heart failure. A significant increase in functional
capacity after exercise training is associated with a lower inci-
dence of cardiac events during follow-up.
(J Am Coll Cardiol 1998;31:1027–34)
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Patients with ischemic heart disease and left ventricular (LV)
dysfunction have a reduced exercise tolerance because of a
reduced ability of the circulatory supply of oxygen in meeting
the cellular metabolic requirements under conditions of phys-
ical stress. There is evidence that exercise training can reduce
the functional impairment by inducing both central and pe-
ripheral adaptations (1,2). Although peripheral modifications
represent the major contributors to the improvement in exer-
cise tolerance after exercise training, it is still a matter of
debate whether exercise conditioning can increase myocardial
contractility and whether this increase can contribute to the
improvement in the exercise tolerance of these patients.
In the past, increases in both myocardial perfusion and
contractility have been described after an adequate training
stimulus in patients with chronic coronary artery disease and
different levels of LV dysfunction (3–6). The extent of im-
provement in LV function in response to physical activity
seemed more marked among patients with provokable myo-
cardial ischemia or effort angina, or both, than in patients
without them. An explanation could be that only viable/isch-
emic myocardium retains the capability to improve function
after restoration of adequate perfusion to chronically under-
perfused dysfunctional myocardium.
The relation between perfusion and function is evidenced
by the objective improvement in rest LV ejection fraction
(LVEF) obtained in 25% to 40% of patients with ischemic
cardiomyopathy who undergo coronary artery bypass surgery
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or percutaneous transluminal coronary angioplasty (7,8). Thus,
the search for an accurate and noninvasive method for detect-
ing viable myocardium has become an important component of
the diagnostic assessment of patients with depressed LV
function. Among them, low dose dobutamine stress echocar-
diography (LDSE) has the unique capability to evaluate the
contractile response of dysfunctional myocardium. Only viable
myocardium is capable of enhancing contractile function in
response to inotropic stimulation and its assessment has been
demonstrated to have predictive value as well as prognostic
significance (9,10).
On the basis of these premises, we hypothesized that
moderate exercise training could improve LV contractility in
patients with chronic heart failure due to ischemic cardiomy-
opathy. These effects can contribute to an increase in func-
tional capacity and also have prognostic implications.
Methods
Patients. Over a 2-year period, 71 consecutive patients
56 6 9 years old (range 35 to 68 y) with chronic heart failure
were studied. All patients were in sinus rhythm and clinically
stable for the 3 months preceding the study. Chronic heart
failure was diagnosed when definite radiographic evidence of
pulmonary congestion was associated with typical signs and
symptoms of heart failure for .3 months. All patients had had
one or more myocardial infarctions during the past 2 years.
LVEF was 33 6 6% (mean 6 SD). Twelve patients had
undergone coronary artery bypass graft surgery. Patients with
a recent myocardial infarction (,3 months), unstable angina,
high grade arrhythmias, uncontrolled hypertension, uncom-
pensated congestive heart failure, hemodynamically significant
valvular heart disease, renal insufficiency (serum creatinine
.2.2 mg/dl) and orthopedic limitations were excluded. All
patients had coronary angiography within 6 months of the
beginning of the study. Forty-three percent of patients had
.70% lumen narrowing of all three major epicardial coronary
arteries; 38% of patients had two-vessel disease; and 19% had
one stenotic vessel. Medications were similar in the two groups
and were not altered throughout the study.
Protocol. The protocol was approved by the ethics Com-
mittee of Lancisi Hospital, Ancona, Italy. All patients provided
written informed consent and were randomized to an exercise
group (group T) or a control group (group C) (Table 1). At
baseline and at the end of the study all patients underwent an
LDSE study and an incremental exercise test with gas ex-
change analysis.
Dobutamine stress echocardiography. Echocardiographic
studies were performed with the patient supine in the left
lateral position. Under continuous electrocardiographic
(ECG) monitoring, dobutamine was infused into a peripheral
vein at an incremental regimen of 5 mg/kg body weight per min
every 3 minutes until a maximum of 20 mg/kg per min. Systolic
blood pressure was taken at baseline and at the end of each
stage. End points of the study included a new wall motion
abnormality, significant ST segment changes (i.e., ST segment
depression or elevation $1 mm or more in two contiguous
leads), significant symptoms or arrhythmias or completion of
the protocol. A 12-lead ECG recording was taken every minute
with pediatric sized precordial electrodes to maximize the
chest area available for echocardiography. Two-dimensional
echocardiographic images were continuously recorded from
the parasternal long-axis, short axis and apical four- and
two-chamber views using a wide-angle mechanical scanner
(Challenge-ESAOTE).
Measurements. End-diastole was defined as the frame coin-
ciding with the peak of the R wave of the QRS complex on the
ECG. End-systole was defined as the frame at the end of the T
wave. LV end-diastolic volume and end-systolic volume were
obtained from the apical four- and two-chamber views using a
modified Simpson’s rule, from which LVEF was automatically
calculated as the difference between end-diastolic volume
(EDV) and end-systolic volume (ESV) normalized to EDV.
Table 1. Clinical Characteristics of 71 Study Patients
Exercise Group
(n 5 36)
Control Group
(n 5 35)
Male/female 31/5 30/5
Age (yr) 55 6 9 57 6 9
MI 36 35
Ant 19 18
Inf 6 7
Lat 2 2
Ant1Inf 9 8
Peak V˙O2 (ml/kg per min) 16.2 6 4 16 6 4
LVEF (%) 33 6 6 31 6 7
NYHA functional class
II 27 25
III 9 10
Medications
Nitrates 26 28
Diuretic drugs 16 15
ACE inhibitors 32 31
Aspirin 16 16
Warfarin 20 19
Data presented are mean value 6 SD or number of patients. ACE 5
angiotensin-converting enzyme; Ant 5 anterior; Inf 5 inferior; Lat 5 lateral;
LVEF 5 left ventricular ejection fraction; MI 5 myocardial infarction; NYHA 5
New York Heart Association; V˙O2 5 oxygen uptake.
Abbreviations and Acronyms
ECG 5 electrocardiographic
LDSE 5 low dose dobutamine stress echocardiography
LV 5 left ventricular
LVEDV 5 left ventricular end-diastolic volume
LVEDVI 5 left ventricular end-diastolic volume index
LVEF 5 left ventricular ejection fraction
LVESV 5 left ventricular end-systolic volume
LVESVI 5 left ventricular end-systolic volume index
Peak V˙O2 5 oxygen uptake at peak exercise
SWTI 5 systolic wall thickening score index
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We used a biplane algorithm to calculate LV volumes (11). A
16-segment model was used for analysis, as recommended by
the American Society of Echocardiography (11). Each segment
was visually graded using a semiquantitative scoring system,
where 1 5 normal; 2 5 hypokinetic; 3 5 akinetic; and 4 5
dyskinetic. A regional systolic wall thickening score index
(SWTI) was defined as the sum of each segment score divided
by the number of interpreted segments. Abnormal regional wall
motion was defined as a value falling outside the established
95% confidence intervals for each segment for a normal
population database from our laboratory. Normal values from
our laboratory were calculated from a group of 150 healthy
subjects (75 men, 75 women; mean age 54 6 17 years, range 19
to 80) consecutively studied by three independent, experienced
physicians. All subjects underwent three echocardiographic
studies on different days over 2 weeks. A mean value for LV
volumes (LV end-diastolic volume index [LVEDVI] 53.9 6 8.7
ml/m2; LV end-systolic volume index [LVESVI] 22.5 6 5
ml/m2) and derived LVEF (58.1 6 6.9%) was obtained from
five consecutive cycles for each study. To test the intraobserver
variability, each study was reexamined by the same observer on
a separate day (EDV 0.91 6 15 ml; ESV 1.5 6 11 ml; LVEF
0.9 6 6.6%). A second observer reviewed each study to test
for interobserver variability (EDV 0.05 6 12 ml; ESV 21.1 6
10.8 ml; LVEF 1.9 6 8.4%).
The regional systolic wall thickening score index (SWTI)
was calculated at rest and at each stage of dobutamine
infusion. A 20% reduction in SWTI represents the 95%
confidence interval, discriminating a significant difference be-
tween normal and abnormal contractile response to low dose
dobutamine by two-dimensional echocardiography in our lab-
oratory.
Data analysis. All studies were analyzed with an off-line
system equipped with digital processing (Panasonic AG 7700).
Representative cycles of rest and peak dobutamine dose
images in comparable views were digitized and positioned side
by side on a quad screen format. The echocardiographic
images were evaluated in a blinded manner by two indepen-
dent, experienced observers who adopted the same assessment
criteria. Disagreement between the two observers occurred in
6% of the studies. Differences in interpretation were resolved
by a third independent cardiologist. A response was considered
normal when segments with normal wall thickening at rest had
a persistent hyperdynamic response to dobutamine. A viable
response was considered an improvement in SWTI by at least
one grade in two adjacent segments with rest asynergy at any
stage of dobutamine infusion (i.e., from score 3 at rest to 2 or
1 during infusion). An ischemic response was considered the
development of hypokinesia, akinesia or dyskinesia from nor-
mal segments at rest or initial improvement in wall thickening
from an abnormal segment at rest followed by worsening
thickening at higher doses of dobutamine infusion. On
follow-up studies, improvement in the contractile response to
dobutamine, compared with baseline studies, was considered a
reduction in SWTI by $1 at peak infusion or a $20%
reduction in SWTI in at least two adjacent segments, or both.
Cardiopulmonary exercise test. All patients performed a
familiarization incremental exercise test on a cycle ergometer
1 or 2 weeks before the randomization. On study entry, a
symptom-limited exercise test with gas exchange analysis was
repeated in all patients. Patients pedaled in upright position at
60 rpm with the aid of a visual display on an electronically
braked cycle ergometer (Ergometrics 800, Sensormedics). The
work rate was progressively increased by 1 W every 4 s in a
ramp pattern. Every minute, a 12-lead ECG was recorded, and
blood pressure was measured. During each test, gas exchange
analysis was performed breath by breath (Sensormedics
2900 Z). Peak oxygen uptake (V˙O2) was defined as the average
V˙O2 during the last 15 s of exercise. Ventilatory threshold was
measured by the V-slope method (12). A positive exercise test was
defined by ST segment depression $2 mm in at least two adjacent
ECG leads during exercise persisting .3 min into recovery or ST
segment elevation or angina pectoris, or both, during exercise.
Exercise training. The exercise group underwent a pro-
gram of exercise training of moderate intensity (60% of peak
V˙O2) three times a week for 10 weeks. Control patients
performed no exercise. Each session consisted of a warm-up
phase of stretching exercise and calisthenics (10 to 15 min),
followed by 40 min of cycling on an electronically braked cycle
ergometer. Heart rate and blood pressure were measured at
baseline, at midcycling time and at recovery. A cardiologist was
present during each session. Care was taken to avoid exercise
intensities above or below the initial target. Patients in both
groups were asked not to exercise at home. Both trained and
control patients were visited monthly by a cardiologist in the
hospital.
Follow-up. Patients were followed up for 23 6 6 months
(range 11 to 26) from the day after the completion of the
protocol. The follow-up period ended at the time of study
closure or with a cardiac event. Events were defined as cardiac
death, myocardial infarction, unstable angina and development
of congestive heart failure requiring hospital admission and
potentiation of medical therapy. Patients in both groups were
instructed not to exercise at home on a regular basis. Patients
were visited by a cardiologist at our hospital every 6 months.
During the follow-up period, patients or their families filled in
a standard questionnaire at home to be shown at any visit to
provide information about home activities, symptoms and
medications.
Statistical analysis. A two-tailed Student t test was used
for intragroup (paired) and intergroup (unpaired) compari-
sons. The effects of exercise training on metabolic and hemo-
dynamic variables were analyzed by two-way analysis of vari-
ance. The effects of exercise training on the contractile
response to dobutamine and functional capacity were analyzed
on the basis of patients rather than myocardial segments to
increase the power of statistical analysis.
Patients were classified as those with and without a viable/
ischemic response. A score was created, where 0 5 no change;
11 5 improvement; and 21 5 deterioration. Changes in this
score as a function of exercise training versus control were
analyzed using a nonparametric test (Mann-Whitney rank
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test). The Fisher exact test was used to determine whether the
response of the SWTI during dobutamine infusion on study
entry predicted the improvement in functional capacity after
exercise training.
Univariate analysis to assess correlations between pre- and
posttraining changes in peak V˙O2 and all clinical, echocardio-
graphic and metabolic variables was performed. Variables with
significant correlations (p , 0.05) were then entered into a
stepwise linear regression model to determine the best predic-
tors of posttraining improvement in functional capacity. The
effect of covariates on the outcome was assessed by stepwise
logistic regression analysis. Cardiac mortality was compared
between groups by means of log-rank tests. Cardiac event-free
curves for the trained and untrained patients were computed
using the Kaplan-Meier method. Results expressed as mean
value 6 SD. Statistical significance was assumed for p # 0.05.
Results
Patients. All patients completed the exercise training pro-
tocol. As shown in Table 2, trained patients had significant
improvements in peak V˙O2 (28%), ventilatory threshold
(31%), ventilation at peak exercise (33%) and work rate
(21%). Compared with control subjects, all these changes were
statistically significant. No differences in respiratory exchange
ratio and heart rate at peak exercise were observed in the two
groups.
Eleven patients in the exercise group and 10 in the control
group had a positive ECG stress test at baseline. After 10
weeks, 8 of the 11 patients who underwent exercise training
and none of the control patients had a negative ECG stress test
(p , 0.001).
Dobutamine stress echocardiography. All patients at-
tained the peak dose of dobutamine (20 mg/kg per min). No
major complications occurred during dobutamine stress test-
ing. One patient had a nonsustained ventricular tachycardia
(19 beats); two patients had atrial tachycardia; and seven
patients had isolated premature ventricular contractions. Hy-
potension occurred in two patients after the completion of the
test. There were no significant differences in end-diastolic
diameter, heart rate or systolic blood pressure between pa-
tients with and without viable myocardium. The number of
coronary arteries with significant stenoses was not different in
patients with and without contractile response.
Effects of exercise training on LV function. Of the 71
patients who underwent LDSE at baseline, 36 had viable
myocardium (19 in group T, 17 in group C), 30 (42%) had a
positive inotropic response to dobutamine, and 6 (8%) had an
ischemic response only. Rest SWTI and LVEF were similar in
patients who underwent exercise training and patients who did
not (Table 3). After 10 weeks, both SWTI and LVEF at peak
dobutamine levels improved significantly in trained patients
only (25% and 27%, respectively, p , 0.001 trained vs. control
for both variables). The improvement in LVEF at peak
dobutamine was due to a reduction in LVESVI (223%; p ,
0.001). There were neither significant differences in LVEDVI
nor changes in systolic blood pressure at any relative work rate,
indicating that changes in SWTI and LVEF at peak dobut-
amine were unrelated to changes in loading conditions.
Table 2. Metabolic and Hemodynamic Variables on Study Entry and at 10 Weeks
Exercise Group Control Group
p
Value*
Study
Entry 10 wk
Study
Entry 10 wk
Peak oxygen uptake (ml/kg per min) 16.2 6 3 20.8 6 4 16 6 3 16.3 6 3 0.001
Ventilatory threshold (ml/kg per min) 10.9 6 2 14.3 6 2 10.5 6 2 10.6 6 2 0.001
Ventilation (liter/min) 46 6 9 61 6 12 49 6 11 48 6 12 0.001
Respiratory exchange ratio 1.15 6 0.05 1.16 6 0.07 1.16 6 0.05 1.16 6 0.05 0.26
Work rate (W) 108 6 20 131 6 25 101 6 22 103 6 22 0.001
Rest heart rate (beats/min) 86 6 11 76 6 8 82 6 9 85 6 10 0.001
Peak heart rate (beats/min) 137 6 17 139 6 10 135 6 10 138 6 15 0.88
Peak systolic blood pressure (mm Hg) 168 6 24 175 6 23 160 6 20 155 6 21 0.007
Rate-pressure product (beats/min 3 mm Hg) 22,797 6 4,607 24,474 6 6,671 21,980 6 4,370 21,867 6 4,452 0.005
*Changes after 10 weeks, exercise versus control group by unpaired t test.
Table 3. Rest and Peak Hemodynamic Variables on Dobutamine
Stress Echocardiography at Baseline and at 10 Weeks
Exercise Group Control Group
Baseline 10 wk Baseline 10 wk
Rest
HR (beats/min) 88 6 10 79 6 9 90 6 8 93 6 10
LVEDVI (ml/m2) 101 6 6 99 6 7 104 6 8 106 6 10
LVESVI (ml/m2) 68 6 8 67 6 9 70 6 10 72 6 11
LVEF (%) 34 6 6 33 6 7 33 6 5 32 6 8
SWTI 2.2 6 0.2 2.1 6 0.2 2.3 6 0.3 2.2 6 0.3
Peak
HR (beats/min) 137 6 7 135 6 9 133 6 10 137 6 9
LVEDVI (ml/m2) 92 6 5 90 6 5 95 6 9 97 6 10
LVESVI (ml/m2) 58 6 8 42 6 9* 60 6 11 63 6 10
LVEF (%) 37 6 7 53 6 10 38 6 8 39 6 9
SWTI 1.89 6 0.2 1.52 6 0.2* 1.91 6 0.3 1.90 6 0.3
*p , 0.001, exercise group versus control group. HR 5 heart rate;
LVEDVI 5 left ventricular end-diastolic volume index; LVEF 5 left ventricular
ejection fraction; LVESVI 5 left ventricular end-systolic volume index; SWTI 5
systolic wall thickening score index.
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More specifically, 45 of 206 hypokinetic segments at base-
line improved the SWTI after exercise training, along with 38
of 94 akinetic and 2 of 17 dyskinetic segments. Only 6% of
myocardial segments (17 of 291) in the control group improved
contractility on follow-up studies (chi-square 46.3; p , 0.001,
group T vs. group C).
Prediction of improvement in functional capacity by LDSE.
Of the 19 patients in the exercise group with a positive
contractile response to dobutamine at baseline, 16 had a
significant improvement in peak V˙O2 after exercise training
(from 16.6 6 2 to 20.6 6 3 ml/kg per min, p , 0.001). Of the
17 patients with no evidence of viable myocardium on the
initial LDSE, 7 had an increased peak V˙O2 after exercise
training (from 15.9 6 2 to 19.5 6 2 ml/kg per min, p , 0.001).
Ten patients with no viable myocardium at baseline had no
significant increase in peak V˙O2 after exercise training (base-
line 13.5 6 0.8 ml/kg per min; study end 14.2 6 0.9 ml/kg per
min, p 5 0.10). Positive and negative predictive values of
LDSE were 84% and 59%, respectively. Of interest, the
subgroup of patients with viable myocardium and improved
functional capacity after exercise training had a higher peak
V˙O2 and a lower SWTI at baseline than the subgroup of
patients with no viable myocardium on the initial LDSE and no
increase in functional capacity after exercise training (Table 4).
As shown in Figure 1, patients with viable myocardium and
improved functional capacity had a significantly greater im-
provement in posttraining rest peak LVEF and SWTI in
response to dobutamine infusion than patients with no viable
myocardium and no improvement in functional capacity.
Moreover, there were no significant differences in heart rate,
systolic blood pressure or LV end-diastolic dimension between
patients with and without contractile improvement, suggesting
that the presence of contractile response to dobutamine was
independent of heart rate, afterload or preload.
Outcome. Completed follow-up data were obtained in all
patients over a period of 23 6 6 months. Cardiac events
occurred in 8 group T patients (22%) and 18 group C patients
(51%) (p , 0.001, group T vs. group C). As shown in Figure 2,
the number of patients at risk in each group was 34 and 30 at
12 months, and 28 and 17 at 24 months, respectively. Cardiac
events in the eight patients of the group T were cardiac death
in one patient, unstable angina in two, acute myocardial
infarction in two and hospital admission for worsening heart
failure in three. In the control group, cardiac death occurred in
four patients, unstable angina in five, acute myocardial infarc-
tion in three and worsening heart failure in six. Patients with a
cardiac event had a significantly higher SWTI at baseline than
patients with no cardiac events (2.04 6 0.2 vs. 1.83 6 0.2, p 5
0.02). No significant differences in age, gender, heart rate at
rest and peak exercise, peak V˙O2, peak systolic blood pressure,
Table 4. Clinical and Rest Echocardiographic Variables in Patients With Viable Myocardium at Baseline and Improvement in Functional
Capacity After Exercise Training and in Patients Without Viable Myocardium at Baseline and No Improvement in Functional Capacity After
Exercise Training
CS1 Peak V˙O21 (n 5 16) CS2 Peak V˙O22 (n 5 10)
Study Entry 10 wk D Study Entry 10 wk D
HR (beats/min) 82 6 11 71 6 9 11 6 10* 80.7 6 14 78 6 14 2.3 6 14
Peak V˙O2 (ml/kg per min) 16.6 6 2 20.6 6 3 23 6 3* 13.5 6 0.8 14.2 6 0.9 20.7 6 0.9
LVEF (%) 34.3 6 6.5 33.6 6 8 0.68 6 4 31.6 6 7 30.7 6 7 0.89 6 2.6
LVEDVI (ml/m2) 99 6 5 96.4 6 5 2.6 6 3 102 6 6 99.4 6 7.3 2.78 6 5.4
LVESVI (ml/m2) 65.6 6 9 64.1 6 10 1.48 6 3 70.9 6 7.7 70 6 8 0.9 6 2.6
SWTI 2 6 0.07 2 6 0.09 0.01 6 0.08* 2.5 6 0.1 2.35 6 0.2 0.15 6 0.2
*p , 0.001 for changes (D) between the two subgroups. CS1 Peak V˙O21 5 viable myocardium at baseline and improved functional capacity after exercise training;
CS2 Peak V˙O22 5 no viable myocardium at baseline and no improvement in functional capacity after exercise training; other abbreviations as in Tables 1 and 3.
Figure 1. LVEF and SWTI at rest and
peak dobutamine infusion in each individ-
ual patient with viable myocardium who
improved functional capacity after exer-
cise training (CS1 VO2Peak1) and each
patient without viable myocardium who
had no change in functional capacity after
10 weeks (CS1 VO2Peak2). Solid cir-
cles 5 mean values. *p , 0.001, CS1
VO2Peak 1 versus CS1 VO2Peak2.
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resting LVEF and LV volumes were observed between pa-
tients with and without cardiac events. There was no significant
difference between the prevalence of risk factors or medication
between patients of the two groups with and without cardiac
events.
Univariate and multivariate analysis. Stepwise linear re-
gression analysis showed that group (trained or untrained)
(chi-square 28.618, p , 0.001), pre- to posttraining changes in
work capacity (chi-square 8.115, p , 0.004) and SWTI at
baseline (chi-square 8.282, p 5 0.004) were the best indepen-
dent predictors of improvement in functional capacity after
exercise conditioning. Stepwise logistic regression analysis with
event as the outcome showed that the pre- to posttraining
change in LVEF at peak dobutamine and the presence of a
viable response at baseline were the best significant discrimi-
nant variables (p 5 0.004 and 0.008, respectively) (Table 5).
The survival model (log-rank test) showed significantly lower
event-free survival in patients who underwent the exercise
training program (p , 0.001).
Discussion
The results of the present longitudinal study indicate that,
in patients with chronic heart failure, exercise training of
moderate intensity increases both functional capacity and the
contractile response of hibernating myocardium to low dose
dobutamine. The identification of hibernating myocardium at
baseline by LDSE was associated with a sensitivity of 70% and
a specificity of 77% for predicting an increase in functional
capacity after exercise training. Positive and negative predic-
tive values were 84% and 59%, respectively. A significant
increase in functional capacity, observed only in the trained
group, was associated with a lower incidence of cardiac events
during follow-up (p , 0.001).
Exercise training and myocardial contractility. Our find-
ings confirm the results of a recent preliminary report (13)
showing that a moderate exercise training regimen can im-
prove LV contractility in patients with chronic heart failure
and ischemic heart disease. In the past, similar results were
obtained using exercise training protocols of higher intensities
and longer duration (14,15). With both moderate and intense
exercise training regimens, LV contractility did not change at
baseline. However, the results of the present study indicate
that myocardial contractility may improve in response to
moderate beta-adrenergic stimulation. From our data, this
improvement seems unrelated to changes in loading condi-
tions. In fact, both peak exercise systolic blood pressure and
LVEDVI were unchanged after training.
The improvement in LV contractility in response to a
moderate physical regimen was more marked among patients
with provokable myocardial ischemia or effort angina, or both,
than in patients with no inducible ischemia or who were
asymptomatic. A possible explanation may be that only isch-
emic or viable myocardium retains the capability to improve
function after physical training. Moreover, a remarkable result
from the present study was that 73% of positive exercise tests
at baseline became negative after exercise training (p , 0.001
vs. control subjects). As previously demonstrated in animals
(16,17) and humans with (1,6) and without (18) coronary artery
disease, exercise training can improve LV function through
improvements in myocardial perfusion sustained by both struc-
tural and functional coronary artery adaptations (19–21). The
effect of moderate exercise training should be more evident at
the level of small coronary vessels because the severity of
epicardial stenoses was unchanged after training (22). There-
fore, one mechanism for improvement in LV contractility
could be a reduction in myocardial ischemia. This hypothesis
was confirmed by the absence of spontaneous improvement in
contractility as well as ischemic threshold in untrained patients
on the follow-up study. It is likely that exercise training
determines an improvement in myocardial oxygenation rather
than a lower myocardial oxygen requirement (1). In fact, we
found a posttraining increase in peak exercise heart rate, which
indicates a higher myocardial oxygen demand.
Clinical and prognostic implications. Patients with hiber-
nating myocardium at baseline had a higher peak V˙O2 as well
as a lower SWTI after training (Table 4). We also found that
the improvement in contractility was more marked among less
dysfunctional myocardial segments at baseline. In fact, a
quantitative correlation between the extent of viable myocar-
dium assessed by positron emission tomography and the
magnitude of improvement in heart failure symptoms and
functional capacity has recently been demonstrated after cor-
onary artery bypass surgery in patients with ischemic cardio-
myopathy (23). Although the effects of exercise training on LV
function cannot be compared with those obtained with stan-
dard procedures of myocardial revascularization, these prelim-
inary observations suggest that even a short-term regimen of
Figure 2. Event-free rates in patients who underwent exercise training
(thick line) and control patients (thin line). Numbers of patients at risk
in each group on study entry at 12 and 24 months are shown in
parentheses. Trained patients have a significantly lower probability of
cardiac events than sedentary control patients during follow-up; *p ,
0.001 by log-rank test.
Table 5. Multivariate Analysis of Events as Dependent Variable
Event Beta-Coefficient p Value
DLVEF (%) 74.8 0.004
CS1 at baseline 21.7 0.008
CS1 5 presence of viable myocardium; DLVEF 5 change in left ventricular
ejection fraction before and after training.
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moderate physical activity may induce a favorable effect on
myocardial contractility. Because we did not use high doses of
dobutamine we could not assess the contractile reserve of
dysfunctional myocardium. Nonetheless, the enhanced con-
tractility after moderate inotropic stimulation can be extrapo-
lated to situations of daily life when mild to moderate physical
activities are performed. The implication is that quality of life
can be improved by improvement in LV contractility.
Furthermore, patients who completed the exercise training
regimen had a significantly lower occurrence of untoward
cardiac events during follow-up than did the untrained pa-
tients. Stepwise logistic regression analysis with event as the
outcome selected the pre- to posttraining change in LVEF at
peak dobutamine infusion and the presence of hibernating
myocardium at baseline as the best discriminant variables.
Most patients with no viable response at baseline had no
improvement in either LV contractility or functional capacity
after training, and they also had an adverse outcome.
Thus, the presence of hibernating myocardium at baseline
represents the “conditio sine qua non” to obtain an improve-
ment in LV function as well as functional capacity after
exercise training. Both factors can cooperate to improve the
clinical outcome. It is unclear why patients who underwent
exercise training for only 10 weeks had a lower incidence of
cardiac events than control patients over the following 2 years.
In fact, central adaptations after exercise training are generally
lost after a few weeks of inactivity, even in well trained healthy
humans (24). It is likely that a higher exercise tolerance after
training, in conjunction with an improved LV contractility, can
allow a more active lifestyle, which in turn can maintain a
higher functional capacity for a longer period than expected.
Study limitations. As with any imaging technique, LDSE
has advantages and disadvantages. The advantages are repro-
ducibility, good specificity and compliance. The disadvantages
are subjective interpretation of data, relatively low sensitivity
and lack of an accurate quantitative method for assessing wall
motion abnormalities and wall thickening.
The use of dobutamine at doses #20 mg/kg per min could
lead to underestimation of the contractile response. However,
Panza et al. (25) showed that the great majority of myocardial
segments respond to doses #20 mg/kg per min. Moreover, in
the setting of severe coronary artery stenosis, dobutamine may
provoke ischemic rather than contractile response. Another
cause of underestimation of myocardial viability may be the
absence of a contractile response despite normal perfusion.
This behavior has been described when subendocardial necro-
sis occurs and LV thickening is significantly reduced or absent.
In this case, the contribution of the middle and outer layers of
the LV wall to thickening is modest or negligible.
Conclusions. Patients with chronic heart failure secondary
to ischemic heart disease can improve their functional capacity
with exercise training of moderate intensity, whereas patients
who do not exercise have no significant change in their
functional capacity. A significant posttraining increase in LV
contractility was also observed, supporting the implication that
even short-term moderate exercise training can improve qual-
ity of life by improving LV function during mild to moderate
physical activities. The identification of dysfunctional but via-
ble myocardium by LDSE is predictive of posttraining im-
provement in functional capacity. Importantly, patients with
improved functional capacity after exercise training had a
better outcome than patients who did not exercise. These
findings suggest that LDSE can be usefully employed for
identifying patients with chronic heart failure who will benefit
most from exercise training. In contrast, the absence of a viable
response at baseline can predict patients who will not benefit
from exercising and who will not have a favorable clinical
outcome. The clinical and prognostic significance of these data
need to be confirmed in larger studies.
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